Bushu expects to double the volume of Amgen drugs it makes under new Asia CMO pactnews2021-11-24T15:38:47+00:00November 24th, 2021|Fierce Pharma|
Sun Pharma loses bid to drop Ranbaxy antitrust case; jury trail set for Januarynews2021-11-24T15:25:57+00:00November 24th, 2021|Fierce Pharma|
Takeda’s post-transplant CMV drug Livtencity, shouldering $800M in sales expectations, scores FDA nodnews2021-11-24T15:19:45+00:00November 24th, 2021|Fierce Pharma|
After Biden admin failed to submit FDA chief paperwork on time, hopes for a speedy confirmation vote likely dashed: reportnews2021-11-24T14:04:30+00:00November 24th, 2021|Fierce Pharma|
Sanofi’s Icy Hot teams up with Shaquille O’Neal Foundation to help people rise up from pain—this time, mental painnews2021-11-24T12:12:56+00:00November 24th, 2021|Fierce Pharma|
FDA, working to tackle pandemic inspection backlog, struggles with foreign oversight and site visits for new drugsnews2021-11-23T18:14:21+00:00November 23rd, 2021|Fierce Pharma|
Sanofi coughs up $180M to settle Pompe disease royalty payment disputenews2021-11-23T17:06:46+00:00November 23rd, 2021|Fierce Pharma|
AstraZeneca CEO questions mRNA vaccine superiority, raising theory that his company’s shot offers longer-lasting protectionnews2021-11-23T14:54:45+00:00November 23rd, 2021|Fierce Pharma|
Pfizer to become $100B behemoth next year thanks to COVID-19 drug and vaccine: analystnews2021-11-23T14:52:52+00:00November 23rd, 2021|Fierce Pharma|
Closed-loop system offers promise of automated overdose therapynews2021-11-23T14:15:35+00:00November 23rd, 2021|Fierce Pharma|
